Minocycline/rifampicin(Citius Pharmaceuticals Inc)

N/A

Report date: 2026/03/06 20:02:51

Base Information

Drug NameMinocycline/rifampicin(Citius Pharmaceuticals Inc)
Drug Alias NameCITI-101
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitorsBacterial DNA-directed RNA polymerase inhibitorsPoly (ADP-Ribose) polymerase 1 inhibitors
Targets30S ribosomal subunitBacterial DNA-directed RNA polymerasePoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsInfections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Rifampicin
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMd Anderson Cancer Center Orlando
China Registration ClassN/A

Develop Information

Active CompaniesMd Anderson Cancer Center Orlando
Inactive CompaniesN/A
Active IndicationsInfections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A